Skip to main navigation Skip to search Skip to main content

Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization

  • Izabela P. Klaska
  • , Anne White
  • , Pilar Villacampa
  • , Justin Hoke
  • , Laura Abelleira-Hervas
  • , Ryea N. Maswood
  • , Robin R. Ali
  • , Catey Bunce
  • , Richard D. Unwin
  • , Garth J.S. Cooper
  • , Paul N. Bishop
  • , James W. Bainbridge*
  • *Corresponding author for this work
  • UCL University College London
  • GSTT Guy's and St Thomas' NHS Foundation Trust
  • University of Manchester
  • Josep Carreras Leukaemia Research Institute
  • School of Population Health & Environmental Sciences
  • Manchester Royal Eye Hospital

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science